{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T01:44:57Z","timestamp":1777081497063,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s40256-023-00587-4","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T05:01:36Z","timestamp":1684472496000},"page":"429-440","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cost-Effectiveness and Budget Impact of a Novel Antithrombotic Drug Removal System to Reduce Bleeding Risk in Patients on Preoperative Ticagrelor Undergoing Cardiac Surgery"],"prefix":"10.1007","volume":"23","author":[{"given":"Benjamin G.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francine","family":"Chingcuanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie M.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efthymios N.","family":"Deliargyris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William V.","family":"Padula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,19]]},"reference":[{"key":"587_CR1","doi-asserted-by":"crossref","unstructured":"Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN, et al on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics47\u20132020 update: a report from the American Heart Association. Circulation. 2020;141:e139\u2013e596.","DOI":"10.1161\/CIR.0000000000000757"},{"key":"587_CR2","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1016\/j.clinthera.2015.06.007","volume":"37","author":"A Zbrozek","year":"2015","unstructured":"Zbrozek A, Magee G. Cost of bleeding in trauma and complex cardiac surgery. Clin Ther. 2015;37:1966\u201374.","journal-title":"Clin Ther"},{"key":"587_CR3","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1001\/jamacardio.2017.0265","volume":"2","author":"B Redfors","year":"2017","unstructured":"Redfors B, Watson BM, McAndrew T, Palisaitis E, Francese DP, Razavi M, Safirstein J, Mehran R, Kirtane AJ, G\u00e9n\u00e9reux P. Mortality, length of stay, and cost implications of procedural bleeding after percutaneous interventions using large-bore catheters. JAMA Cardiol. 2017;2:798\u2013802.","journal-title":"JAMA Cardiol."},{"key":"587_CR4","unstructured":"BRILINTA\u00ae (ticagrelor) tablets. https:\/\/www.brilinta.com. Published 2022. Accessed 20 Aug 2022."},{"key":"587_CR5","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1161\/CIRCULATIONAHA.121.058519","volume":"145","author":"JS Lawton","year":"2022","unstructured":"Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, Bittl JA, Cohen MG, DiMaio JM, Don CW, et al. 2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145:e4\u201317.","journal-title":"Circulation"},{"key":"587_CR6","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.athoracsur.2019.01.086","volume":"107","author":"M Holm","year":"2019","unstructured":"Holm M, Biancari F, Khodabandeh S, Gherli R, Airaksinen J, Mariscalco G, Gatti G, Reichart D, Onorati F, De Feo M, et al. Bleeding in patients treated with ticagrelor or clopidogrel before coronary artery bypass grafting. Ann Thorac Surg. 2019;107:1690\u20138.","journal-title":"Ann Thorac Surg"},{"key":"587_CR7","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.athoracsur.2012.04.005","volume":"94","author":"B Bhaskar","year":"2012","unstructured":"Bhaskar B, Dulhunty J, Mullany DV, Fraser JF. Impact of blood product transfusion on short and long-term survival after cardiac surgery: more evidence. Ann Thorac Surg. 2012;94:460\u20137.","journal-title":"Ann Thorac Surg"},{"key":"587_CR8","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1161\/CIRCULATIONAHA.107.698977","volume":"116","author":"GJ Murphy","year":"2007","unstructured":"Murphy GJ, Reeves BC, Rogers CA, Rizvi SIA, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation. 2007;116:2544\u201352.","journal-title":"Circulation"},{"key":"587_CR9","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1097\/01.CCM.0000217920.48559.D8","volume":"34","author":"CG Koch","year":"2006","unstructured":"Koch CG, Li L, Duncan AI, Mihaljevic T, Cosgrove DM, Loop FD, Starr NJ, Blackstone EH. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med. 2006;34:1608\u201316.","journal-title":"Crit Care Med"},{"key":"587_CR10","first-page":"6584631","volume":"2022","author":"MH Liu","year":"2022","unstructured":"Liu MH, Yu H, Zhou RH. Application of adsorptive blood purification techniques during cardiopulmonary bypass in cardiac surgery. Oxidat Med Cell Longev. 2022;2022:6584631.","journal-title":"Oxidat Med Cell Longev."},{"key":"587_CR11","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1177\/0267659120967827","volume":"36","author":"V Mendes","year":"2021","unstructured":"Mendes V, Colombier S, Verdy F, Bechtold X, Schlaepfer P, Scala E, Schneider A, Kirsch M. CytoSorb\u00ae hemoadsorption of apixaban during emergent cardio-pulmonary bypass: a case report. Perfusion. 2021;36:873\u20135.","journal-title":"Perfusion"},{"key":"587_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.athoracsur.2018.12.032","volume":"108","author":"K Hassan","year":"2019","unstructured":"Hassan K, Kannmacher J, Wohlmuth P, Budde U, Schmoeckel M, Geidel S. Cytosorb adsorption during emergency cardiac operations in patients at high risk of bleeding. Ann Thorac Surg. 2019;108:45\u201351.","journal-title":"Ann Thorac Surg"},{"key":"587_CR13","doi-asserted-by":"publisher","first-page":"186","DOI":"10.5761\/atcs.oa.21-00154","volume":"28","author":"K Hassan","year":"2022","unstructured":"Hassan K, Br\u00fcning T, Caspary M, Wohlmuth P, Pioch H, Schmoeckel M, Geidel S. Hemoadsorption of rivaroxaban and ticagrelor during acute type a aortic dissection operations. Ann Thorac Cardiovasc Surg. 2022;28:186\u201392.","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"587_CR14","first-page":"036","volume":"8","author":"R Tripathi","year":"2022","unstructured":"Tripathi R, Morales J, Lee V, Gibson CM, Mack MJ, Schneider DJ, Douketis J, Sellke FW, Ohman EM, Thourani VH, Storey RF, Deliargyris EN. Antithrombotic drug removal from whole blood using haemoadsorption with a porous polymer bead sorbent. Eur Heat J Cardiovasc Pharmacother. 2022;8:036.","journal-title":"Eur Heat J Cardiovasc Pharmacother."},{"key":"587_CR15","unstructured":"Safe and Timely Antithrombotic Removal\u2014Ticagrelor (STAR-T). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04976530. Published 2021. Accessed 20 Aug 2021."},{"key":"587_CR16","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s41669-019-00183-w","volume":"4","author":"M Javanbakht","year":"2020","unstructured":"Javanbakht M, Trevor M, Rezaei Hemami M, Rahimi K, Branagan-Harris M, Degener F, Adam D, Preissing F, Scheier J, Cook SF, Mortensen E. Ticagrelor removal by CytoSorb\u00ae in patients requiring emergent or urgent cardiac surgery: a UK-based cost-utility analysis. PharmacoEcon Open. 2020;4:307\u201319.","journal-title":"PharmacoEcon Open."},{"key":"587_CR17","first-page":"135","volume":"2","author":"GO Angheloiu","year":"2017","unstructured":"Angheloiu GO, Gugiu GB, Ruse C, Pandey R, Dasari RR, Whatling C. Ticagrelor removal from human blood. Basic Transl Sci. 2017;2:135\u201345.","journal-title":"Basic Transl Sci."},{"key":"587_CR18","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1161\/CIRCULATIONAHA.116.022572","volume":"136","author":"SJ Head","year":"2017","unstructured":"Head SJ, Milojevic M, Taggart DP, Puskas JD. Current practice of state-of-the-art surgical coronary revascularization. Circulation. 2017;136:1331\u201345.","journal-title":"Circulation"},{"key":"587_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2147\/RMHP.S130341","volume":"10","author":"M Kilgore","year":"2017","unstructured":"Kilgore M, Patel HK, Kielhorn A, Maya JF, Sharma P. Economic burden of hospitalizations of Medicare beneficiaries with heart failure. Risk Manag Healthc Policy. 2017;10:63.","journal-title":"Risk Manag Healthc Policy."},{"key":"587_CR20","doi-asserted-by":"publisher","first-page":"e003327","DOI":"10.1161\/CIRCOUTCOMES.116.003327","volume":"10","author":"Z Zheng","year":"2017","unstructured":"Zheng Z, Zhang H, Yuan X, Rao C, Zhao Y, Wang Y, Normand SL, Krumholz HM, Hu S. Comparing outcomes of coronary artery bypass grafting among large teaching and urban hospitals in China and the United States. Circ Cardiovasc Qual Outcomes. 2017;10:e003327.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"587_CR21","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1053\/j.semtcvs.2020.11.013","volume":"33","author":"JA Brown","year":"2021","unstructured":"Brown JA, Kilic A, Aranda-Michel E, Navid F, Serna-Gallegos D, Bianco V, Sultan I. Long-term outcomes of reoperation for bleeding after cardiac surgery. Semin Thorac Cardiovasc Surg. 2021;33:764\u201373.","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"587_CR22","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.athoracsur.2020.10.023","volume":"112","author":"I Sultan","year":"2021","unstructured":"Sultan I, Bianco V, Brown JA, Kilic A, Habertheuer A, Aranda-Michel E, Navid F, Humar R, Wang Y, Gleason TG. Long-term impact of perioperative red blood cell transfusion on patients undergoing cardiac surgery. Ann Thorac Surg. 2021;112:546\u201354.","journal-title":"Ann Thorac Surg"},{"key":"587_CR23","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.jtcvs.2009.02.021","volume":"133","author":"MC Christensen","year":"2009","unstructured":"Christensen MC, Krapf S, Kempel A, von Heymann C. Costs of excessive postoperative hemorrhage in cardiac surgery. J Thorac Cardiovasc Surg. 2009;133:687\u201393.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"587_CR24","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1016\/j.jtcvs.2014.07.040","volume":"148","author":"EM Kinnunen","year":"2014","unstructured":"Kinnunen EM, Juvonen T, Airaksinen KE, Heikkinen J, Kettunen U, Mariscalco G, Biancari F. Clinical significance and determinants of the universal definition of perioperative bleeding classification in patients undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2014;148:1640\u20136.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"587_CR25","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/j.athoracsur.2018.10.077","volume":"107","author":"RM Shah","year":"2019","unstructured":"Shah RM, Zhang Q, Chatterjee S, Cheema F, Loor G, Lemaire SA, Wall MJ Jr, Coselli JS, Rosengart TK, Ghanta RK. Incidence, cost, and risk factors for readmission after coronary artery bypass grafting. Ann Thorac Surg. 2019;107:1782\u20139.","journal-title":"Ann Thorac Surg"},{"key":"587_CR26","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.hrtlng.2011.08.006","volume":"41","author":"MA Dolansky","year":"2012","unstructured":"Dolansky MA, Zullo MD, Hassanein S, Schaefer JT, Murray P, Boxer R. Cardiac rehabilitation in skilled nursing facilities: a missed opportunity. Heart Lung. 2012;41:115\u201324.","journal-title":"Heart Lung"},{"key":"587_CR27","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jamcollsurg.2012.11.009","volume":"216","author":"JD Price","year":"2013","unstructured":"Price JD, Romeiser JL, Gnerre JM, Shroyer AL, Rosengart TK. Risk analysis for readmission after coronary artery bypass surgery: developing a strategy to reduce readmissions. J Am Coll Surg. 2013;216:412\u20139.","journal-title":"J Am Coll Surg"},{"key":"587_CR28","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.ahj.2011.11.016","volume":"163","author":"GW Stone","year":"2012","unstructured":"Stone GW, Clayton TC, Mehran R, Dangas G, Parise H, Fahy M, Pocock SJ. Impact of major bleeding and blood transfusions after cardiac surgery: analysis from the acute catheterization and urgent intervention triage strategy (ACUITY) trial. Am Heart J. 2012;163:522\u20139.","journal-title":"Am Heart J"},{"key":"587_CR29","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1161\/CIRCULATIONAHA.114.009985","volume":"130","author":"DJ Cohen","year":"2014","unstructured":"Cohen DJ, Osnabrugge RL, Magnuson EA, Wang K, Li H, Chinnakondepalli K, Pinto D, Abdallah MS, Vilain KA, Morice MC, et al. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the synergy between percutaneous coronary intervention with TAXUS and cardiac surgery (SYNTAX) trial. Circulation. 2014;130:1146\u201357.","journal-title":"Circulation"},{"key":"587_CR30","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2017.6233","volume":"153","author":"CP Childers","year":"2018","unstructured":"Childers CP, Maggard-Gibbons M. Understanding costs of care in the operating room. JAMA Surg. 2018;153: e176233.","journal-title":"JAMA Surg"},{"key":"587_CR31","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1111\/trf.16606","volume":"61","author":"SJ Mowla","year":"2021","unstructured":"Mowla SJ, Sapiano MR, Jones JM, Berger JJ, Basavaraju SV. Supplemental findings of the 2019 National Blood Collection and Utilization Survey. Transfusion. 2021;61:S11\u201335.","journal-title":"Transfusion"},{"key":"587_CR32","unstructured":"Office of Procurement, Acquisition, and Logistics. https:\/\/www.va.gov\/opal\/nac\/fss\/pharmprices.asp. 2021."},{"key":"587_CR33","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1513\/AnnalsATS.201506-366BC","volume":"12","author":"HB Gershengorn","year":"2015","unstructured":"Gershengorn HB, Garland A, Gong MN. Patterns of daily costs differ for medical and surgical intensive care unit patients. Ann Am Thorac Soc. 2015;12:1831\u20136.","journal-title":"Ann Am Thorac Soc"},{"key":"587_CR34","unstructured":"State Health Facts\u2014hospital adjusted expenses per inpatient day, 2019. https:\/\/www.kff.org\/health-costs\/state-indicator\/expenses-per-inpatient-day\/?currentTimeframe=1&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D. 2021."},{"key":"587_CR35","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.jtcvs.2017.08.144","volume":"155","author":"JH Mehaffey","year":"2018","unstructured":"Mehaffey JH, Hawkins RB, Byler M, Charles EJ, Fonner C, Kron I, Quader M, Speir A, Rich J, Ailawadi G. Virginia Cardiac Services Quality Initiative. Cost of individual complications following coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2018;155:875\u201382.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"587_CR36","doi-asserted-by":"publisher","first-page":"e006449","DOI":"10.1161\/CIRCOUTCOMES.119.006449","volume":"13","author":"MP Thompson","year":"2020","unstructured":"Thompson MP, Yost ML, Syrjamaki JD, Norton EC, Nathan H, Theurer P, Prager RL, Pagani FD, Likosky DS. Sources of hospital variation in postacute care spending after cardiac surgery. Circ Cardiovasc Qual Outcomes. 2020;13:e006449.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"587_CR37","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12955-018-1019-3","volume":"16","author":"B Doble","year":"2018","unstructured":"Doble B, Pufulete M, Harris JM, Johnson T, Lasserson D, Reeves BC, Wordsworth S. Health-related quality of life impact of minor and major bleeding events during dual antiplatelet therapy: a systematic literature review and patient preference elicitation study. Health Qual Life Outcomes. 2018;16:191.","journal-title":"Health Qual Life Outcomes"}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-023-00587-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40256-023-00587-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-023-00587-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T13:10:36Z","timestamp":1688735436000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40256-023-00587-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,19]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["587"],"URL":"https:\/\/doi.org\/10.1007\/s40256-023-00587-4","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,19]]},"assertion":[{"value":"20 April 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was funded by CytoSorbents Corporation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"JZ, VL, and END are employees of CytoSorbents Corporation. BGC, FC, NMR, and WVP provided consulting services to CytoSorbents Corporation for Stage Analytics; NMR and WVP are equity holders of Stage Analytics.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Conceptualization: Jingwei Zhang, Victoria Lee, Efthymios N. Deliargyris; methodology: Benjamin G. Cohen, Francine Chingcuanco, Natalie M. Reid, Jonathon Hong; William V. Padula; formal analysis and investigation: Benjamin G. Cohen, Francine Chingcuanco, Jonathon Hong, Natalie M. Reid, William V. Padula; writing\u2014original draft preparation: Benjamin G. Cohen, Francine Chingcuanco, Jingwei Zhang, Natalie M. Reid; writing\u2014reviewing and editing: Efthymios N. Deliargyris, William V. Padula; supervision: Jonathon Hong, Efthymios N. Deliargyris, William V. Padula; funding acquisition: Jingwei Zhang, Victoria Lee, Efthymios N. Deliargyris; visualization: Benjamin G. Cohen, Francine Chingcuanco.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors' contributions"}},{"value":"The datasets generated during and\/or analyzed during the current study are available from the corresponding author on reasonable request.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability statement"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}